Back to Cubist Systematic Strategies, LLC Cubist Systematic Strategies, LLC

CRVSCRVS
9 quarters

Position history for Cubist Systematic Strategies, LLCCubist Systematic Strategies, LLC's holdings in CORVUS PHARMACEUTICALS INC

No. Cubist Systematic Strategies exited its CRVS (Corvus Pharmaceuticals) position in Q4 2024. Its Q3 2024 13F listed 10,026 shares worth $52,937. Cubist Systematic Strategies first reported CRVS in Q3 2021 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$97,000

Total Shares Change

-20,052

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$5.25
0
2024-Q3
Decreased
10,026
-58.9%
$52,9370.0%$5.15
0
2024-Q2
New
24,364
-
$44,3420.0%$1.82
28
2023-Q3
Exited
0
-100.0%
$00.0%$1.46
0
2023-Q2
New
15,552
-
$35,6140.0%$2.23
28
2022-Q2
Exited
0
-100.0%
$00.0%$1.02
0
2022-Q1
Decreased
6,600
-71.6%
$11,0000.0%$1.57
0
2021-Q4
Increased
23,245
+15.9%
$56,0000.0%$2.46
24
2021-Q3
New
20,052
-
$97,0000.0%$6.32
30

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used